BONEX Stock Overview An orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally. More details
Rewards Risk Analysis See All Risk Checks Capture your thoughts, links and company narrative
Bonesupport Holding AB (publ) Competitors Price History & Performance
Summary of share price highs, lows and changes for Bonesupport Holding Historical stock prices Current Share Price SEK 380.40 52 Week High SEK 384.40 52 Week Low SEK 172.50 Beta 0.99 1 Month Change 13.48% 3 Month Change 22.71% 1 Year Change 111.33% 3 Year Change 886.77% 5 Year Change 1,085.05% Change since IPO 1,088.75%
Recent News & Updates
Price target increased by 16% to kr402 Dec 13
Bonesupport Holding AB (publ) Announces Nomination Committee Changes Nov 29
Insider recently sold kr10m worth of stock Nov 21
Price target increased by 12% to kr362 Nov 16
Insider recently sold kr1.7m worth of stock Nov 07
Now 21% undervalued Nov 04 See more updates
Price target increased by 16% to kr402 Dec 13
Bonesupport Holding AB (publ) Announces Nomination Committee Changes Nov 29
Insider recently sold kr10m worth of stock Nov 21
Price target increased by 12% to kr362 Nov 16
Insider recently sold kr1.7m worth of stock Nov 07
Now 21% undervalued Nov 04
Earnings Troubles May Signal Larger Issues for Bonesupport Holding (STO:BONEX) Shareholders Oct 31
Erik Selin acquired 5.92% stake in Bonesupport Holding AB (publ) (OM:BONEX) from Odlander, Fredrikson & Co. AB. Oct 31
Insider recently sold kr690k worth of stock Oct 28 Bonesupport Holding AB (publ) to Report Q2, 2025 Results on Jul 15, 2025
Third quarter 2024 earnings released: EPS: kr0.47 (vs kr3.52 in 3Q 2023) Oct 25
Now 22% undervalued Aug 06
Price target increased by 8.6% to kr323 Jul 21
Consensus EPS estimates fall by 12%, revenue upgraded Jul 18
Chief Executive Officer recently sold kr18m worth of stock Jul 17
Second quarter 2024 earnings released: EPS: kr0.42 (vs kr0.08 in 2Q 2023) Jul 12
Consensus EPS estimates fall by 14% Jun 13 Bonesupport Holding AB (Publ) Appoints Anna Stegmark as EVP Quality Management & Regulatory Affairs, with Effect from 1 July 2024
Key Executive recently sold kr3.6m worth of stock Jun 02
Insider recently sold kr478k worth of stock May 01
First quarter 2024 earnings released Apr 26
Full year 2023 earnings: EPS exceeds analyst expectations Apr 22
Price target increased by 14% to kr293 Apr 19
Bonesupport Holding AB (Publ) Announces Resignation of Kristina Ingvar as Executive Vice President Quality Management & Regulatory Affairs Feb 23
Full year 2023 earnings: EPS exceeds analyst expectations Feb 18
Consensus EPS estimates fall by 24%, revenue upgraded Feb 17
Independent Director recently bought kr1.0m worth of stock Dec 18 Bonesupport Holding AB Provides Sales Guidance for the Year 2024 Nov 29
Price target increased by 11% to kr179 Nov 21
Third quarter 2023 earnings released Oct 28 Bonesupport Holding AB (publ) to Report Q1, 2024 Results on Apr 25, 2024
Bone Support Receives “Breakthrough Device Designation” for Cerament® V for the Indication of Bone Infection Oct 17
Independent Director recently bought kr1.1m worth of stock Aug 02
Insider recently bought kr426k worth of stock Jul 17
Second quarter 2023 earnings released: EPS: kr0.08 (vs kr0.25 loss in 2Q 2022) Jul 14
BONESUPPORT Holding AB Announces Strong Long-Term Results with CERAMENT®G for Severe Open Fractures May 26
Insider recently sold kr701k worth of stock May 17
Forecast breakeven date moved forward to 2023 May 15
Chief Executive Officer recently sold kr15m worth of stock May 06
Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind Apr 24
Insider recently sold kr1.4m worth of stock Mar 17
Full year 2022 earnings released: kr1.06 loss per share (vs kr1.34 loss in FY 2021) Feb 19
Price target increased by 17% to kr142 Feb 16
Bonesupport Holding AB (publ), Annual General Meeting, Nov 21, 2023 Jan 24
Director recently bought kr203k worth of stock Jan 01
No independent directors Nov 16 Bonesupport Holding AB (publ) to Report Q3, 2023 Results on Oct 26, 2023
Third quarter 2022 earnings released Oct 28
No longer forecast to breakeven Oct 26
Bonesupport's CERAMENT G Used in First U.S. Patient Cases Oct 26
Forecast to breakeven in 2023 Oct 25
An unknown buyer acquired unknown minority stakes in Bonesupport Holding AB (publ) (OM:BONEX) from Helena Brandt for SEK 0.84 million. Sep 25
Bonesupport Holding AB (publ) Announces Publication of Mid- to Long-Term Data Confirming the Sustained Clinical Effectiveness of CERAMENT G Sep 09
Consensus forecasts updated Jul 22
Second quarter 2022 earnings released: kr0.25 loss per share (vs kr0.42 loss in 2Q 2021) Jul 15
Insider recently bought kr101k worth of stock Jun 14
Forecast breakeven date moved forward to 2023 Jun 01
Price target increased to kr91.00 May 31
BONESUPPORT Receives Market Authorization for CERAMENT G in the US May 19
Forecast breakeven date pushed back to 2024 May 18
Chairman of the Board recently bought kr1.2m worth of stock May 12
Forecast breakeven date pushed back to 2024 May 09
Less than half of directors are independent Apr 27
Full year 2021 earnings: EPS and revenues miss analyst expectations Apr 15
Bonesupport Holding AB (publ) to Report Fiscal Year 2021 Final Results on Apr 13, 2022 Apr 14
We Think Bonesupport Holding (STO:BONEX) Can Easily Afford To Drive Business Growth Mar 16
BONESUPPORT(TM) Announces Delays Within FDA Postpones CERAMENT G De Novo Decision Mar 01
Forecast breakeven date pushed back to 2024 Feb 20
Full year 2021 earnings: EPS exceeds analyst expectations while revenues lag behind Feb 18
Consensus forecasts updated Feb 17
Insider recently bought kr182k worth of stock Dec 08
Third quarter 2021 earnings released Nov 06
We're Not Worried About Bonesupport Holding's (STO:BONEX) Cash Burn Nov 06
Bonesupport Announces Supplementary US Denovo Application Submitted Sep 29
Chief Executive Officer recently bought kr343k worth of stock Sep 22
Price target decreased to kr65.00 Sep 14
Bonesupport Announces Study Results for its Investigational Device Exemption(IDE) Study, Fortify Sep 10
Chief Financial Officer recently bought kr87k worth of stock Aug 14
Insider recently bought kr401k worth of stock Aug 01
Chairman of the board recently bought kr1.6m worth of stock Jul 20
Second quarter 2021 earnings released Jul 17
BONESUPPORTTM Receives Device Designation for CERAMENT G for the Indication Trauma Jun 18
Chief Financial Officer recently bought kr210k worth of stock May 22
Forecast to breakeven in 2023 May 17 Shareholder Returns BONEX SE Biotechs SE Market 7D 10.1% -0.4% -1.6% 1Y 111.3% 12.8% 6.5%
See full shareholder returns
Return vs Market: BONEX exceeded the Swedish Market which returned 6.5% over the past year.
Price Volatility Is BONEX's price volatile compared to industry and market? BONEX volatility BONEX Average Weekly Movement 5.7% Biotechs Industry Average Movement 10.0% Market Average Movement 5.6% 10% most volatile stocks in SE Market 11.4% 10% least volatile stocks in SE Market 3.2%
Stable Share Price: BONEX has not had significant price volatility in the past 3 months compared to the Swedish market.
Volatility Over Time: BONEX's weekly volatility (6%) has been stable over the past year.
About the Company Bonesupport Holding AB (publ), an orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally. The company provides CERAMENT Bone Void Filler, an injectable ceramic bone graft substitute that remodels to host bone; CERAMENT G, an injectable ceramic bone graft substitute that remodels to host bone and elutes Gentamicin during the critical first 30 days of bone healing, as well as treats and prevents bone infection; CERAMENT V, an injectable ceramic bone graft substitute that remodels to host bone and elutes Vancomycin during the critical first 30 days of bone healing, as well as treats and prevents bone infection. It also offers CERAMENT Bead Tray, an adjunctive local delivery option for surgeons for targeted delivery to osseous defects and for dead space management.
Show more Bonesupport Holding AB (publ) Fundamentals Summary How do Bonesupport Holding's earnings and revenue compare to its market cap? BONEX fundamental statistics Market cap SEK 25.19b Earnings (TTM ) SEK 90.58m Revenue (TTM ) SEK 814.46m
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) BONEX income statement (TTM ) Revenue SEK 814.46m Cost of Revenue SEK 61.64m Gross Profit SEK 752.82m Other Expenses SEK 662.24m Earnings SEK 90.58m
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 25, 2025
Earnings per share (EPS) 1.38 Gross Margin 92.43% Net Profit Margin 11.12% Debt/Equity Ratio 0%
How did BONEX perform over the long term?
See historical performance and comparison
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2024/12/19 20:22 End of Day Share Price 2024/12/19 00:00 Earnings 2024/09/30 Annual Earnings 2023/12/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources Bonesupport Holding AB (publ) is covered by 4 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Maria Vara Fernández Bryan Garnier & Co Kristofer Liljeberg-Svensson Carnegie Investment Bank AB Jonas Peciulis Edison Investment Research
Show 1 more analysts 
